Understanding Personalized Gene Therapy Treatments for Cancer
Performance of Personalized Gene Therapy Treatments for Cancer Cancer arises due to genetic mutations in the DNA of cells that cause them to grow and …
Unleashing Industry Insights, Connecting the Future
Performance of Personalized Gene Therapy Treatments for Cancer Cancer arises due to genetic mutations in the DNA of cells that cause them to grow and …
The biologics market comprises advanced therapies that have revolutionized the treatment of chronic and life-threatening diseases. Biologics are complex large molecule drugs produced from living …
CRISPR technology is a genome editing technique that allows scientists to alter DNA sequences and modify gene function. It has enabled rapid and inexpensive DNA …
The Biopharmaceutical Revolution Over the last few decades, we have seen tremendous advancements in biopharmaceutical and biomedicine research. What began as a focus on developing …
Morquio syndrome, also known as mucopolysaccharidosis type IV (MPS IV), is a life-threatening inherited metabolic disorder caused by a deficiency in the enzyme N-acetylgalactosamine-6-sulfatase (GALNS). …
A groundbreaking study conducted by researchers at NYU Grossman School of Medicine and scientists at Rocket Pharmaceuticals has shown that gene-based therapy has the potential …
The Middle East and Asia Pacific cell and gene therapy market involves the development and application of therapeutic products containing modified cells or genes aimed …
Gene therapy involves modifying genes to treat or cure disease. In recent years, gene therapy has emerged as a promising approach for treating various diseases …
Small scale bioreactors allow the manufacturing and production of therapeutic proteins, monoclonal antibodies, stem cells, cell therapies and vaccines in minimal volumes across pharmaceutical and …
The global Epidermolysis Bullosa Market is estimated to be valued at US$ 3813.38 Mn in 2023 and is expected to exhibit a CAGR of 11% …